| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |